Understanding the Key Differences: Mechanisms and Dosing
What Is the Core Difference Between Wegovy and Mounjaro Mechanisms?
The fundamental difference between Wegovy and Mounjaro lies in their mechanisms of action and how they target appetite regulation. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural fullness hormone, working primarily on brain appetite centres to reduce hunger and promote satiety after smaller meals. Mounjaro, containing tirzepatide, is a dual agonist targeting both GIP and GLP-1 receptors, potentially offering enhanced appetite control through two complementary pathways.
Both medications require the same dose escalation schedule—starting at 0.25mg for weeks 1-4, progressing to 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance dosing. This identical escalation timeline means your choice between Wegovy and Mounjaro won't affect your dosing schedule, but understanding the mechanistic differences can help inform your decision alongside your prescriber's guidance. Both are prescription-only medicines requiring clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity.
Complete Wegovy and Mounjaro Dose Pricing: Every Step of Your Journey
At EverydayMeds, we provide transparent pricing for every dose of both Wegovy and Mounjaro, ensuring no surprises during your escalation journey. Wegovy single pen pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 discount applied), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg and 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg, and 1.7mg) is available for £369.99, providing convenient multi-dose supply.
When comparing what is difference between Wegovy and Mounjaro from a cost perspective, both medications follow similar pricing structures, though storage convenience may influence your choice. Returning customers benefit from our DOSE25 discount code applied at checkout, whilst new customers use FIRST40. Our GPhC-registered pharmacy (#9012878) ensures all doses are maintained in optimal cold-chain storage before dispatch, with next-day delivery once your prescription is approved following clinical assessment.
Clinical Evidence: Understanding What Is Different Between Wegovy and Mounjaro Trials
The clinical evidence for Wegovy comes primarily from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP trials demonstrated sustained weight management across different populations, including those with type 2 diabetes and participants receiving intensive behavioural therapy support.
Mounjaro's evidence stems from the SURMOUNT trials, showing the dual GIP/GLP-1 mechanism's potential in weight management contexts. However, direct head-to-head comparisons between these trials aren't appropriate due to different study designs, populations, and endpoints. Both medications demonstrate efficacy when used as prescribed, and both are available from EverydayMeds with comprehensive clinical support to help determine which option aligns with your individual circumstances.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy's active ingredient, semaglutide, works by mimicking the natural hormone GLP-1 (glucagon-like peptide-1) that your body produces after eating. This hormone normally signals to your brain that you're satisfied and reduces the desire to continue eating, but in many people, this natural signalling becomes less effective over time. By activating GLP-1 receptors in the brain, Wegovy may help restore this natural appetite regulation, leading to reduced food intake and decreased cravings. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Additionally, Wegovy may influence reward pathways in the brain associated with food pleasure, potentially reducing the appeal of high-calorie foods that often contribute to weight gain.
Ordering Process: From Assessment to All Doses Available
Our streamlined ordering process ensures access to every dose of both Wegovy and Mounjaro through a comprehensive yet efficient pathway. The journey begins with our 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any contraindications that might influence prescribing decisions. Following submission, your assessment undergoes review by our qualified prescribers, with standard processing taking 3 working days or express review available within 24 hours for urgent requirements. Once approved, your medication is dispatched via next-day delivery using temperature-controlled packaging to maintain the cold-chain integrity essential for these injectable medicines. Our GPhC-registered pharmacy status (#9012878) ensures all handling meets pharmaceutical standards, from storage through to your door. Whether you're starting with 0.25mg doses or progressing to 2.4mg maintenance, our system tracks your escalation schedule and can alert you when it's time to progress to the next dose level.
Storage and Practical Differences: What Is Different Between Wegovy and Mounjaro Convenience
Understanding storage differences between Wegovy and Mounjaro becomes particularly important as you progress through all dose levels over many months of treatment. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability, remaining effective for up to 6 weeks below 30°C once removed from the fridge. Mounjaro provides 21 days of room temperature storage, which while adequate for most situations, offers less flexibility for travel or lifestyle convenience. Both use pre-filled injection pens—Wegovy's FlexTouch system and Mounjaro's KwikPen—designed for once-weekly subcutaneous administration. The dose escalation timeline remains identical regardless of which medication you choose: 4 weeks each at 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching 2.4mg maintenance dosing. This standardised approach ensures your treatment timeline remains predictable whether you're using Wegovy or Mounjaro throughout your weight management journey.
Lifetime Treatment Planning: What Is the Difference Between Wegovy and Mounjaro Long-term?
When considering what is difference between Wegovy and Mounjaro for long-term treatment, both medications represent ongoing commitments rather than short-term interventions, with the 2.4mg maintenance dose typically continuing indefinitely for sustained weight management. Clinical evidence suggests that discontinuing either medication often leads to weight regain, with STEP trial extensions showing patients regained approximately two-thirds of lost weight within one year of stopping treatment. This reality makes choosing a reliable pharmacy partner crucial, as you'll need consistent access to maintenance doses for potentially many years.
EverydayMeds addresses this long-term need by maintaining comprehensive stock of all doses, eliminating the common problem of patients having to source their medication from multiple providers as they progress through treatment phases. Our bundle options, such as the Ultimate Stability Trio (three 2.4mg pens for £649.99), cater specifically to maintenance phase requirements, whilst our dose-specific bundles support the escalation phase. Whether your prescriber recommends Wegovy's GLP-1 mechanism or Mounjaro's dual GIP/GLP-1 approach, our pharmacy can support your entire treatment journey from initial 0.25mg doses through lifelong maintenance.
Making Your Decision: Both Wegovy and Mounjaro Available
Ultimately, the choice between Wegovy and Mounjaro depends on individual factors that your prescriber will evaluate during the clinical assessment process, considering your medical history, previous weight management attempts, other medications, and personal circumstances. Both are prescription-only medicines with proven efficacy in clinical trials, and both require the same commitment to dose escalation and lifestyle modifications including reduced-calorie diet and increased physical activity. At EverydayMeds, we've eliminated the pharmacy-related barriers to either choice by maintaining complete stock of all doses from both manufacturers, ensuring your treatment isn't interrupted by supply issues regardless of which medication proves most suitable. Our clinical team can provide additional guidance during the assessment process, helping you understand the practical implications of each option. Whether you proceed with Wegovy's established GLP-1 mechanism or Mounjaro's dual-action approach, our comprehensive service includes new customer discount code FIRST40 and returning customer code DOSE25 applied at checkout, with next-day delivery ensuring prompt treatment initiation once prescribed.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
